Clinical Trial Update: Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the mechanism of action of sitagliptin in combination with pioglitazone in type 2 diabetes mellitus; the trial has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone (Actos) (pioglitazone)
• Sitagliptin (Januvia) (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED | Results posted: 2010-03-05